IMAX (IMAX) Resumen de Acciones
IMAX Corporation, junto con sus filiales, opera como plataforma tecnológica de entretenimiento y eventos en Estados Unidos, Canadá, Gran China, resto de Asia, Europa Occidental, Latinoamérica y a escala internacional. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 4/6 |
| Crecimiento futuro | 3/6 |
| Rendimiento pasado | 3/6 |
| Salud financiera | 5/6 |
| Dividendos | 0/6 |
Recompensas
Análisis de riesgos
IMAX Community Fair Values
Create NarrativeSee what 21 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Is this the AI replacing marketing professionals?
Key Takeaways EVA Live (Nasdaq:GOAI) has launched NeuroServer , a purpose-built AI system trained specifically for digital advertising rather than built on off-the-shelf AI models. Its custom neural architecture is designed for multi-objective optimisation across real campaign KPIs, and was trained using reinforcement learning in an agency environment, positioning it very differently from typical AI-powered ad-tech tools.
Read full narrativeCompetidores de IMAX Corporation
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$36.51 |
| Máximo en las últimas 52 semanas | US$43.16 |
| Mínimo de 52 semanas | US$22.54 |
| Beta | 0.40 |
| Cambio en 1 mes | -9.02% |
| Variación en 3 meses | 2.44% |
| Cambio de 1 año | 50.00% |
| Variación en 3 años | 83.93% |
| Variación en 5 años | 74.52% |
| Variación desde la OPV | 461.69% |
Noticias y actualizaciones recientes
IMAX: Global Premium Footprint Expansion Will Shape Future Earnings Power
The analyst price target for IMAX edges higher to about $41.09 from $41.00 as analysts incorporate mixed target moves across firms, modest adjustments to revenue growth and margin assumptions, and slightly higher future P/E expectations. Analyst Commentary Recent Street research on IMAX presents a mixed picture, with several firms lifting price targets while a smaller group trims expectations and highlights areas of risk.
IMAX: Premium Theatrical Formats And Strong Box Office Will Drive Future Upside
The IMAX analyst price target edges higher to about $45.27 from $45.00, as analysts factor in recent target raises tied to strong Q4 results, higher box office activity, robust system installs, and expectations for continued importance within the global theatrical ecosystem. Analyst Commentary Recent Street research on IMAX clusters around higher price targets and generally positive reactions to the latest quarterly results, box office trends, and system installation activity.Recent updates
IMAX: Global Premium Footprint Expansion Will Shape Future Earnings Power
The analyst price target for IMAX edges higher to about $41.09 from $41.00 as analysts incorporate mixed target moves across firms, modest adjustments to revenue growth and margin assumptions, and slightly higher future P/E expectations. Analyst Commentary Recent Street research on IMAX presents a mixed picture, with several firms lifting price targets while a smaller group trims expectations and highlights areas of risk.IMAX: Premium Theatrical Formats And Strong Box Office Will Drive Future Upside
The IMAX analyst price target edges higher to about $45.27 from $45.00, as analysts factor in recent target raises tied to strong Q4 results, higher box office activity, robust system installs, and expectations for continued importance within the global theatrical ecosystem. Analyst Commentary Recent Street research on IMAX clusters around higher price targets and generally positive reactions to the latest quarterly results, box office trends, and system installation activity.IMAX: Future Earnings Base And Global Footprint Frame Balanced Opportunity And Risk
Narrative Update: IMAX Analyst Price Target Shift The analyst price target for IMAX has moved to $41.00. Analysts cite record share gains, accelerating international expansion, strong Q4 and full-year revenue and margins, and continued outperformance versus consensus as key factors influencing their updated views.IMAX: Record Box Office And Premium Format Position Will Support Future Upside
The analyst price target for IMAX is raised by about $1 to $45.00, as analysts factor in higher margin expectations, a lower assumed future P/E multiple, and recent research citing strong quarterly results, record box office driven revenue, and a stronger position in the global theatrical ecosystem. Analyst Commentary Recent research updates show a cluster of target price increases for IMAX, with analysts reacting to reported results, box office trends, and the company’s role in premium theatrical formats.IMAX: Future Earnings Base And International Footprint Suggest Balanced Opportunity And Risk
The Analyst Price Target for IMAX has increased from $22.04 to $41.00. This reflects analysts' views that recent record revenue, strong margins, higher box office activity and an expanding international footprint support a higher assumed profit margin and P/E multiple in updated models.
IMAX: Live Sports And Content Partnerships Will Support Future Upside
Analysts have maintained their $47.00 price target on IMAX, citing updated assumptions around discount rate, revenue growth, profit margin, and a higher future P/E multiple. They also highlight broader sector risks such as high development costs, dependence on single assets, and limited near term catalysts in comparable coverage.IMAX: Future Slate And Execution Will Support Expanded Premium Format Opportunities
Analysts have inched their price target for IMAX higher to approximately US$44.09 from about US$43.73, reflecting updated assumptions around revenue growth, profit margins and future P/E levels. Analyst Commentary Analysts have updated their IMAX models around revenue, margins and future P/E levels, which feeds directly into the small lift in the price target to about US$44.09.IMAX: Future Slate And Profit Execution Will Support Measured Upside Potential
Analysts have lifted their IMAX fair value estimate from about US$38.81 to roughly US$43.73 per share, citing updated assumptions for revenue growth, profit margins and a lower future P/E that together support a higher price target. Analyst Commentary Analysts reviewing IMAX after the updated fair value estimate are split between what could support the higher valuation and what might limit upside if execution falls short.IMAX Corporation: Strong Network Effect And Visible Growth Ahead
Jan 09IMAX: Premium Screens And Local Language Hits Will Support Future Upside
Analysts have raised their price target on IMAX to $40 from $36, citing record Q3 global box office results, an increasing market share, strong local language titles, and faster-than-expected network expansion in markets with above-average revenue per screen. Analyst Commentary Bullish analysts point to IMAX's recent record Q3 global box office results and its second highest quarterly gross as key supports for their updated views, highlighting what they see as solid execution across the business.IMAX: Expanding Premium Network Will Drive Stronger Box Office Performance
Analysts have lifted their price target on IMAX to approximately $47 from about $38, citing accelerating network expansion into higher revenue markets, record and resilient box office performance, and an expectation for stronger, more profitable growth that, in their view, supports a lower forward earnings multiple versus historical levels. Analyst Commentary Bullish analysts have recently highlighted IMAX as one of the stronger execution stories in the theatrical ecosystem, pointing to a mix of box office outperformance, premium market exposure, and disciplined capital deployment as key supports for higher valuation.IMAX: Future Slate And Premium Screen Expansion Will Drive Measured Performance
We raise our IMAX price target to approximately $39 from about $37, as analysts highlight record Q3 box office performance, accelerating high value screen expansion, and a robust Q4 film slate that together support modestly stronger growth and valuation assumptions. Analyst Commentary Recent Street commentary on IMAX has tilted clearly positive, with multiple firms raising price targets in response to stronger than expected operating trends and an improving growth outlook.IMAX: Future Box Office Releases And Network Expansion Will Shape Performance
IMAX's analyst price target has increased significantly, rising from $36 to $37 per share to $40 to $42 per share, as analysts cite strong quarterly box office results, ongoing network expansion, and promising upcoming film releases as key drivers of growth. Analyst Commentary Recent updates from street research provide insights into the positive momentum behind IMAX's upgraded price targets, as well as areas of continued scrutiny among analysts.IMAX: Accelerating Network Expansion Will Drive Global Box Office Performance
The analyst consensus price target for IMAX has increased from approximately $36.45 to $37.18. Analysts highlight strong box office performance and accelerating network expansion as key drivers for the upward revision.North America And Japan Installations Will Strengthen Premium Entertainment
Analysts have raised their price target for IMAX from approximately $34.36 to $36.45. They cite stronger box office performance, accelerating network expansion, and improved margins as key factors supporting the higher valuation.North America And Japan Installations Will Strengthen Premium Entertainment
IMAX's analyst price target has been raised from $31 to $38, reflecting higher expected margins and valuation multiples according to analysts. Analyst Commentary Analyst sentiment toward IMAX has recently shifted, leading to an upward revision of the company's price target.Earnings Tell The Story For IMAX Corporation (NYSE:IMAX) As Its Stock Soars 25%
Sep 09
Is Now An Opportune Moment To Examine IMAX Corporation (NYSE:IMAX)?
Aug 04An Intrinsic Calculation For IMAX Corporation (NYSE:IMAX) Suggests It's 32% Undervalued
Jun 13Market Participants Recognise IMAX Corporation's (NYSE:IMAX) Earnings Pushing Shares 25% Higher
May 17IMAX's (NYSE:IMAX) Soft Earnings Are Actually Better Than They Appear
May 02Should You Investigate IMAX Corporation (NYSE:IMAX) At US$22.45?
Apr 19Here's What's Concerning About IMAX's (NYSE:IMAX) Returns On Capital
Apr 04We Think IMAX (NYSE:IMAX) Can Stay On Top Of Its Debt
Mar 15IMAX Corporation: Unlocking Asymmetric Gains In Premium Cinema
Mar 09Is Now The Time To Look At Buying IMAX Corporation (NYSE:IMAX)?
Jan 08IMAX Corporation: Overseas Growth Opportunities
Dec 24IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively
Dec 10IMAX Corporation (NYSE:IMAX) Shares Could Be 44% Below Their Intrinsic Value Estimate
Nov 23After Leaping 26% IMAX Corporation (NYSE:IMAX) Shares Are Not Flying Under The Radar
Nov 07Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly
Oct 31If EPS Growth Is Important To You, IMAX (NYSE:IMAX) Presents An Opportunity
Oct 13IMAX Corporation: Undervalued Relative To Revenue Growth And Margin Expansion Potential
Oct 10When Should You Buy IMAX Corporation (NYSE:IMAX)?
Sep 30
Calculated Global Expansion And Innovative Content Slate Set To Propel Growth
IMAX's strategic expansions and landmark deals in global markets promise substantial revenue growth through new installations and high-profile film releases.Returns On Capital At IMAX (NYSE:IMAX) Paint A Concerning Picture
Aug 23IMAX Corporation: Upbeat Mid-Term Outlook After Great Q2 Signings
Jul 30Pinning Down IMAX Corporation's (NYSE:IMAX) P/S Is Difficult Right Now
Jul 26Is IMAX (NYSE:IMAX) A Risky Investment?
Jun 19Is It Too Late To Consider Buying IMAX Corporation (NYSE:IMAX)?
May 22IMAX Corporation: Good Reasons To Be Bullish
Apr 08IMAX Corporation Just Recorded A 12% EPS Beat: Here's What Analysts Are Forecasting Next
Mar 01Rentabilidad de los accionistas
| IMAX | US Entertainment | Mercado US | |
|---|---|---|---|
| 7D | -1.6% | -1.3% | 0.9% |
| 1Y | 50.0% | -5.7% | 28.2% |
Rentabilidad vs. Industria: IMAX superó a la industria US Entertainment, que obtuvo un rendimiento del -5.7% el año pasado.
Rentabilidad vs. Mercado: IMAX superó al mercado US, que obtuvo un rendimiento del 28.2% el año pasado.
Volatilidad de los precios
| IMAX volatility | |
|---|---|
| IMAX Average Weekly Movement | 6.3% |
| Entertainment Industry Average Movement | 9.3% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.2% |
Precio estable de las acciones: IMAX no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado US.
Volatilidad a lo largo del tiempo: La volatilidad semanal de IMAX (6%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1967 | 679 | Robert Lister | www.imax.com |
IMAX Corporation, junto con sus filiales, opera como plataforma tecnológica de entretenimiento y eventos en Estados Unidos, Canadá, Gran China, resto de Asia, Europa Occidental, Latinoamérica e internacionalmente. Opera a través de los segmentos de Soluciones de contenido y Productos y servicios tecnológicos. La empresa ofrece remasterización de películas IMAX, una tecnología patentada que remasteriza digitalmente películas y otros contenidos en formatos IMAX para su distribución a la red IMAX; IMAX Enhanced, que proporciona tecnología de extremo a extremo a través de contenidos de streaming y dispositivos de entretenimiento en el hogar; soluciones de calidad de vídeo impulsadas por IA para medios de comunicación y empresas de entretenimiento; y productos de software de tecnología de streaming.
Resumen de fundamentos de IMAX Corporation
| Estadísticas fundamentales de IMAX | |
|---|---|
| Capitalización bursátil | US$2.01b |
| Beneficios(TTM) | US$36.78m |
| Ingresos (TTM) | US$404.92m |
¿Está IMAX sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de IMAX | |
|---|---|
| Ingresos | US$404.92m |
| Coste de los ingresos | US$165.47m |
| Beneficio bruto | US$239.46m |
| Otros gastos | US$202.68m |
| Beneficios | US$36.78m |
Últimos beneficios comunicados
Mar 31, 2026
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.67 |
| Margen bruto | 59.14% |
| Margen de beneficio neto | 9.08% |
| Ratio deuda/patrimonio | 67.9% |
¿Cómo se ha desempeñado IMAX a largo plazo?
Ver rendimiento histórico y comparativaAnálisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/04 14:57 |
| Precio de las acciones al final del día | 2026/05/01 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
IMAX Corporation está cubierta por 20 analistas. 11 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Marla Backer | Ascendiant Capital Markets LLC |
| David McFadgen | ATB Cormark Historical (Cormark Securities) |
| Patrick Sholl | Barrington Research Associates, Inc. |